1. Home
  2. CVAC vs PLAY Comparison

CVAC vs PLAY Comparison

Compare CVAC & PLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • PLAY
  • Stock Information
  • Founded
  • CVAC 2000
  • PLAY 1982
  • Country
  • CVAC Germany
  • PLAY United States
  • Employees
  • CVAC N/A
  • PLAY N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • PLAY Restaurants
  • Sector
  • CVAC Health Care
  • PLAY Consumer Discretionary
  • Exchange
  • CVAC Nasdaq
  • PLAY Nasdaq
  • Market Cap
  • CVAC 1.2B
  • PLAY 1.1B
  • IPO Year
  • CVAC 2020
  • PLAY 1995
  • Fundamental
  • Price
  • CVAC $5.48
  • PLAY $25.85
  • Analyst Decision
  • CVAC Hold
  • PLAY Hold
  • Analyst Count
  • CVAC 3
  • PLAY 8
  • Target Price
  • CVAC $6.83
  • PLAY $31.83
  • AVG Volume (30 Days)
  • CVAC 789.9K
  • PLAY 870.5K
  • Earning Date
  • CVAC 08-18-2025
  • PLAY 09-09-2025
  • Dividend Yield
  • CVAC N/A
  • PLAY N/A
  • EPS Growth
  • CVAC N/A
  • PLAY N/A
  • EPS
  • CVAC 0.87
  • PLAY 1.02
  • Revenue
  • CVAC $566,039,775.00
  • PLAY $2,112,300,000.00
  • Revenue This Year
  • CVAC N/A
  • PLAY $4.00
  • Revenue Next Year
  • CVAC $24.04
  • PLAY $6.58
  • P/E Ratio
  • CVAC $6.35
  • PLAY $25.58
  • Revenue Growth
  • CVAC 787.60
  • PLAY N/A
  • 52 Week Low
  • CVAC $2.37
  • PLAY $15.08
  • 52 Week High
  • CVAC $5.72
  • PLAY $43.73
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 60.60
  • PLAY 40.37
  • Support Level
  • CVAC $5.41
  • PLAY $23.65
  • Resistance Level
  • CVAC $5.54
  • PLAY $26.72
  • Average True Range (ATR)
  • CVAC 0.05
  • PLAY 1.40
  • MACD
  • CVAC -0.01
  • PLAY -0.41
  • Stochastic Oscillator
  • CVAC 73.68
  • PLAY 19.52

About CVAC CureVac N.V.

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About PLAY Dave & Buster's Entertainment Inc.

Dave & Buster's Entertainment Inc owns and operates nearly a hundred entertainment and dining establishments in the United States where customers can eat, drink, play games, and watch televised sports. Each store offers a full menu of entries and appetizers, a complete selection of alcoholic and non-alcoholic beverages, and an extensive assortment of entertainment attractions centered around playing games and watching live sports and other televised events. It derives maximum revenue from Entertainment.

Share on Social Networks: